Roche Molecular Systems, Inc.

Roche Molecular Systems, Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on May 30, 2025 and the most recent on May 30, 2025 (Opulus™ Lymphoma Precision). Its most common review panel is Radiology (1 device).